Rizos H - Search Results

1

Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.

Newell F, Pires da Silva I, Johansson PA, Menzies AM, Wilmott JS, Addala V, Carlino MS, Rizos H, Nones K, Edwards JJ, Lakis V, Kazakoff SH, Mukhopadhyay P, Ferguson PM, Leonard C, Koufariotis LT, Wood S, Blank CU, Thompson JF, Spillane AJ, Saw RPM, Shannon KF, Pearson JV, Mann GJ, Hayward NK, Scolyer RA, Waddell N, Long GV. Newell F, et al. Among authors: rizos h. Cancer Cell. 2022 Jan 10;40(1):88-102.e7. doi: 10.1016/j.ccell.2021.11.012. Epub 2021 Dec 23. Cancer Cell. 2022. PMID: 34951955 Free article.

2

Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.

Holland EA, Beaton SC, Becker TM, Grulet OM, Peters BA, Rizos H, Kefford RF, Mann GJ. Holland EA, et al. Among authors: rizos h. Oncogene. 1995 Dec 7;11(11):2289-94. Oncogene. 1995. PMID: 8570179

3

Differential expression of p16INK4a and p16beta transcripts in B-lymphoblastoid cells from members of hereditary melanoma families without CDKN2A exon mutations.

Rizos H, Becker TM, Holland EA, Kefford RF, Mann GJ. Rizos H, et al. Oncogene. 1997 Jul 31;15(5):515-23. doi: 10.1038/sj.onc.1201217. Oncogene. 1997. PMID: 9247305

4

Multiple abnormalities of the p16INK4a-pRb regulatory pathway in cultured melanoma cells.

Rizos H, Darmanian AP, Indsto JO, Shannon JA, Kefford RF, Mann GJ. Rizos H, et al. Melanoma Res. 1999 Feb;9(1):10-9. doi: 10.1097/00008390-199902000-00003. Melanoma Res. 1999. PMID: 10338330

5

Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.

Rizos H, Darmanian AP, Mann GJ, Kefford RF. Rizos H, et al. Oncogene. 2000 Jun 15;19(26):2978-85. doi: 10.1038/sj.onc.1203629. Oncogene. 2000. PMID: 10871849

6

Mutations in the INK4a/ARF melanoma susceptibility locus functionally impair p14ARF.

Rizos H, Darmanian AP, Holland EA, Mann GJ, Kefford RF. Rizos H, et al. J Biol Chem. 2001 Nov 2;276(44):41424-34. doi: 10.1074/jbc.M105299200. Epub 2001 Aug 22. J Biol Chem. 2001. PMID: 11518711 Free article.

7

Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.

Becker TM, Rizos H, Kefford RF, Mann GJ. Becker TM, et al. Among authors: rizos h. Clin Cancer Res. 2001 Oct;7(10):3282-8. Clin Cancer Res. 2001. PMID: 11595726

8

Impaired inhibition of NF-kappaB activity by melanoma-associated p16INK4a mutations.

Becker TM, Rizos H, de la Pena A, Leclercq IA, Woodruff S, Kefford RF, Mann GJ. Becker TM, et al. Among authors: rizos h. Biochem Biophys Res Commun. 2005 Jul 8;332(3):873-9. doi: 10.1016/j.bbrc.2005.05.032. Biochem Biophys Res Commun. 2005. PMID: 15913553

9

The melanoma-associated 24 base pair duplication in p16INK4a is functionally impaired.

Becker TM, Ayub AL, Kefford RF, Mann GJ, Rizos H. Becker TM, et al. Among authors: rizos h. Int J Cancer. 2005 Nov 20;117(4):569-73. doi: 10.1002/ijc.21265. Int J Cancer. 2005. PMID: 15945100 Free article.

10

Gene expression profiling in melanoma identifies novel downstream effectors of p14ARF.

Packer LM, Pavey SJ, Boyle GM, Stark MS, Ayub AL, Rizos H, Hayward NK. Packer LM, et al. Among authors: rizos h. Int J Cancer. 2007 Aug 15;121(4):784-90. doi: 10.1002/ijc.22725. Int J Cancer. 2007. PMID: 17450523 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page